Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Antibiotics taken during labour and delivery not linked to autism

Antibiotics taken during labour and delivery not linked to autism

Stories Dec 1, 2022 4 minutes

New research answers questions about autism development and perinatal antibiotic use.

A connection between autism spectrum disorder (ASD) and early life antibiotic exposure has been found in some studies. However, research led by Vancouver Coastal Health Research Institute investigator, Dr. Gillian Hanley, found no relationship between the development of ASD among children born to mothers who took antibiotics during labour and delivery of their infant.

ASD is a brain-related condition that often displays as difficulties with social communication and interaction, along with learning and attention differences. It can also result in a person restricting their behaviour or enjoying repetitive tasks. While very heterogeneous, the condition can have a significant impact on a person’s ability to function independently. 

Dr. Gillian Hanley is a Tier 2 Canada Research Chair in Population-Based Gynecologic and Perinatal Outcomes, as well as an assistant professor in the Department of Obstetrics and Gynaecology at the University of British Columbia.

“Because ASD patients often exhibit symptoms of gut dysfunction, there has been a longstanding interest in how medications that might affect bacteria that live in the gut, such as antibiotics, could also impact the brain of ASD patients,” says Hanley. “Since antibiotics are essential to the health of many pregnant mothers, our study investigated one leading concern about their use — including that antibiotics might predispose an unborn child to ASD.”

“It is our responsibility in the medical community to do this research and share it with our patients in support of knowledge acquisition and patient education.” 

Hanley’s study — published in the journal Pediatrics — reviewed clinical information from 569,953 births from 366,152 birth parents in British Columbia between April 1, 2000 and December 31, 2014. With her team, Hanley also reviewed follow-up data until December 31, 2016, at which point children included in the study were a mean age of 8.7 years. 

“This sizable data set has gold standard clinical data on ASD diagnoses, which enables researchers to more confidently rule out a potential precursor to the development of conditions such as ASD.”

Of all children included in the study, 1.53 per cent were at some point diagnosed with ASD. Among the 231,629, or 40.6 per cent, of infants exposed to antibiotics during labour and delivery, 1.66 per cent were later diagnosed with ASD. In comparison, 1.44 of children who were not exposed to antibiotics during labour and delivery were diagnosed with ASD — a total difference of 0.22 percentage points.

However, after controlling for birth-parent sociodemographic and pregnancy-related conditions and risk factors, as well as labour, delivery and neonatal characteristics, the research team found no significant association between antibiotic use during labour and delivery and a diagnosis of ASD.

“We were very careful to control for such things as comorbidities and other factors that could make children more predisposed to develop ASD.”

Women from the study who received antibiotics during labour and delivery tended to be older, lived in urban areas and had higher blood pressure, diabetes and body mass index. Deliveries were more likely to be by caesarean section, involve an epidural and require labour induction. Infants also tended to have higher birth weights, stayed in the womb longer and were admitted to neonatal intensive care units to receive antibiotics.

The important role of antibiotics in labour and delivery

Around 40 per cent of women receive antibiotics during labour and delivery to treat fever or trauma to tissues, as well as for caesarean section care or to treat group B streptococcus (GBS) infections. Mostly a benign bacteria that commonly live in the gastrointestinal or genital tracts, around 25 per cent of pregnant women carry GBS in their bodies. While GBS is rarely passed from mother to child, it can be fatal in four to six per cent of cases when it is.

Pregnant women are often asked to take a GBS test at around 35 to 37 weeks into their pregnancy — with 39 weeks being full-term, when a woman is most likely to go into labour. Women who test positive for GBS have the option to take an antibiotic when in labour, Hanley explains.

“We treat for this risk factor to prevent quite rare, but potentially highly negative outcomes,” says Hanley. 

“The problem is that, in rare cases where babies contract GBS, they can be very, very sick and can die from sepsis caused by the bacteria.”

As a result, physicians recommend that a pregnant woman with GBS take antibiotics to prevent the small chance of severe complications in their newborn baby. Antibiotics can, however, change the microbiome of both a mother and her unborn child, the effects of which are not fully understood in medical science, explains Hanley.

More research is needed to delve deeper into the role of microbial changes in the gut as a result of antibiotic use, including investigating longer durations of antibiotic use throughout pregnancy, Hanley says. This, she adds, will likely continue to be an area of investigation in her research. “However, for now, women and clinicians should feel reassured that treating Group B Strep and other conditions with antibiotics during labour and delivery does not appear to increase a child’s risk for ASD.” 

 

Researchers

Gillian Hanley

Related Articles

Surgical Tattoos in Infrared to optimize robot-guided surgeries

Extreme heat linked to lower cardiac arrest survival in B.C.

Transforming cervical cancer care

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy